WRAL Tech Wire

Pozen Names Novartis Exec as Head of Product Development

Pozen Hires Long-Time Glaxo Executive as CFO

Payment from GSK Lifts Pozen to Profitability -- for First Time

Number of Class Action Suits Against Pozen Hits 11

When You're Hot -- the Giant's CEO Calls Back After a Cold Call; Just Ask StrikeIron.

<b>Networking at the TechExec:</b> CipherOptics' CTO and NCTDA's new manager also have good stories to share. <b>Plus:</b> A ghost of an ISP's past is 'still blinking'. <b>And:</b> Faces in the crowd.

Pozen to Clear $95M in Offering

What a Relief - Positive Test Results for Migrane Drug Send Pozen Stock Soaring 26 Percent

<b>Updated:</b> Good news for MT-100 drug based on two-year carcinogenicity study in rats. Pozen stock had suffered since another drug received 'not-approvable' letter from FDA last fall.

Chief Financial Officer at Pozen Steps Down